Yongqing Dr Li

US Patent:

20070112543, May 17, 2007

Filed:

Nov 15, 2005

Appl. No.:

11/274579

Inventors:

Kevin Harding - Niskayuna NY, US
Jianming Zheng - Shanghai, CN
Yongqing Li - Ann Arbor MI, US
Ming Jia - Shanghai, CN
Guiju Song - Shanghai, CN
Joseph Ross - Cincinnati OH, US
Ralph Isaacs - Cincinnati OH, US

International Classification:

G01B 11/24

US Classification:

702167000

Abstract:

A computer-implemented method, system, and computer program code are provided for characterizing an edge break, e.g., part features and/or geometric discontinuities that could give rise to edge sharpness, as may be encountered in a chamfer, bevel, fillet and other part features. The methodology enables to accurately and consistently determine in a manufacturing setting, for example, any applicable geometric parameter for characterizing the edge break.

US Patent:

20100317047, Dec 16, 2010

Filed:

Feb 5, 2010

Appl. No.:

12/701176

Inventors:

Hasan B. Alam - Natick MA, US
Yongqing Li - West Roxbury MA, US

Assignee:

THE GENERAL HOSPITAL CORPORATION - Boston MA

International Classification:

C12Q 1/02
G01N 33/50

US Classification:

435 29, 436 86

Abstract:

Methods for the use of claudin-3 as a biomarker for diagnosis and prognosis, and for monitoring the efficacy of treatment, in hemorrhagic shock (HS).

US Patent:

20130149713, Jun 13, 2013

Filed:

May 11, 2011

Appl. No.:

13/696530

Inventors:

Hasan B. Alam - Natick MA, US
Yongqing Li - West Roxbury MA, US

Assignee:

THE GENERAL HOSPITAL CORPORATION - Boston MA

International Classification:

G01N 33/68

US Classification:

435 74, 435 792, 435 23

Abstract:

Methods for the use of keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) (KC/GRO), apolipoprotein A2 (APOA2), angiotensinogen r (AGT), thyroglobulin (TG), disintegrin and metalloproteinase domain-containing protein 17 (ADAM17), anionic trypsin-1 (PRSS1), complement C4 (C4A), zona pellucida sperm-binding protein 1 (ZP1), neuropilin-2 (NRP2), solute carrier family 13 member 2 (SLC13A2), glucagon-like peptide 2 receptor (GLP2R), lipoma high mobility group protein isoform I-C (HMGIC) fusion partner-like protein 4 (LHFPL4), and claudin-3 (CLDN3) as biomarkers for diagnosis and prognosis, and for monitoring the efficacy of treatment, in hemorrhagic shock (HS).

US Patent:

20140057829, Feb 27, 2014

Filed:

Feb 1, 2012

Appl. No.:

13/981032

Inventors:

Hasan B. Alam - Ann Arbor MA, US
Yongqing Li - West Roxbury MA, US

Assignee:

THE GENERAL HOSPITAL CORPORATION - Boston MA

International Classification:

G01N 33/68

US Classification:

514 14, 435 792, 514192, 514200, 514 23, 514312, 514376

Abstract:

Methods of diagnosing sepsis, severe sepsis, or septic shock and predicting prognosis in subjects with septic shock, based on levels of citrullinated histone H3 (Cit H3) in the subject, e.g., in a sample comprising serum (e.g., whole blood, serum, or plasma), cerebrospinal fluid, urine, saliva, or peritoneal fluid from the subject.

US Patent:

20180325850, Nov 15, 2018

Filed:

May 11, 2018

Appl. No.:

15/977700

Inventors:

- Ann Arbor MI, US
Francis D. Pagani - Ann Arbor MI, US
Yuqing Chen - Ann Arbor MI, US
Hasan Alam - Ann Arbor MI, US
Yongqing Li - Ann Arbor MI, US

International Classification:

A61K 31/19
A61K 9/00
A61K 45/06
A61K 31/616
A61K 31/4365
A61K 31/04
A61P 9/10

Abstract:

Provided herein are pharmaceutical compositions comprising valproic acid and methods of use thereof for the treatment and/or prevention of myocardial ischemia and/or infarction.

US Patent:

20160333081, Nov 17, 2016

Filed:

Jan 30, 2015

Appl. No.:

15/106550

Inventors:

- Boston MA, US
Yongqing LI - Ann Arbor MI, US

Assignee:

THE GENERAL HOSPITAL CORPORATION - Boston MA

International Classification:

C07K 16/18

Abstract:

The technology described herein is directed to the treatment of sepsis and/or septic shock by, e.g. administering an agent that can reduce the level of circulating citrullated histones.